Histogen Inc (HSTO)
0.20
0.00 (0.00%)
USD |
OTCM |
May 10, 15:32
Histogen Total Assets (Quarterly): 5.817M for Sept. 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 5.817M |
| June 30, 2023 | 13.54M |
| March 31, 2023 | 16.05M |
| December 31, 2022 | 19.07M |
| September 30, 2022 | 22.19M |
| June 30, 2022 | 21.04M |
| March 31, 2022 | 31.50M |
| December 31, 2021 | 27.24M |
| Date | Value |
|---|---|
| September 30, 2021 | 27.56M |
| June 30, 2021 | 30.80M |
| March 31, 2021 | 28.81M |
| December 31, 2020 | 15.01M |
| September 30, 2020 | 13.95M |
| June 30, 2020 | 17.77M |
| December 31, 2019 | 2.942M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
2.942M
Minimum
Dec 2019
31.50M
Maximum
Mar 2022
19.55M
Average
19.07M
Median
Dec 2022
Total Assets (Quarterly) Benchmarks
| CEL-SCI Corp | 28.71M |
| AIM ImmunoTech Inc | 19.38M |
| IGC Pharma Inc | 11.26M |
| NovaBay Pharmaceuticals Inc | 9.034M |
| Protalix BioTherapeutics Inc | 84.43M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.413M |
| Shareholders Equity (Quarterly) | 5.436M |
| Current Ratio | 4.047 |